Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for Mesothelioma
Drug: MRTX1719
Sites in Denver, Lone Tree +20 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05245500·Phase 1·Recruiting·Listed Feb 2022
Oncology Clinical Trials in Denver, CO
As of July 2026, 166 paid clinical trials are recruiting for Oncology in Denver, Colorado. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
168 clinical trials for Oncology
·Clear filters·↓ Download CSVSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for Cancer, Metastatic
Sites in Denver, Aurora +65 more locations
Sponsor: Massive Bio, Inc.
Sex: All·Age: All ages
Code: NCT03452774·Recruiting·Listed Mar 2018
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
for Breast Cancer
Drug: Palazestrant
Sites in Denver, Aurora +38 more locations
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT06016738·Phase 3·Recruiting·Listed Aug 2023
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for Esophageal Squamous Cell Carcinoma
Sites in Denver +14 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07503808·Phase 1·Recruiting·Listed Mar 2026
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Denver +27 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for Lymphoma, Non-Hodgkin's
Drug: LY4584180
Sites in Denver +20 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07226843·Phase 1·Recruiting·Listed Nov 2025
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for HER2-positive Breast Cancer
Sites in Denver +21 more locations
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07102381·Phase 2·Recruiting·Listed Aug 2025
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for Multiple Myeloma
Drug: Daratumumab
Sites in Denver +16 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07095452·Phase 2, Phase 3·Recruiting·Listed Jul 2025
A Study of PHST001 in Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Denver +19 more locations
Sponsor: Pheast Therapeutics
Sex: All·Age: 18+
Code: NCT06840886·Phase 1·Recruiting·Listed Feb 2025
A Study of ASP3082 in Adults With Advanced Solid Tumors
for Solid Tumor
Sites in Denver +23 more locations
Sponsor: Astellas Pharma Inc
Sex: All·Age: 18+
Code: NCT05382559·Phase 1·Recruiting·Listed May 2022
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
for Locally Advanced or Metastatic Solid Tumors
Sites in Denver, Aurora +8 more locations
Sponsor: ArriVent BioPharma, Inc.
Sex: All·Age: 18+
Code: NCT07066657·Phase 1·Recruiting·Listed Jul 2025
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Denver +7 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06120283·Phase 1·Recruiting·Listed Nov 2023
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for Metastatic Solid Tumor
Drug: LY4052031
Sites in Denver +16 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06465069·Phase 1·Recruiting·Listed Jun 2024
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
for SST2-positive Neuroendocrine Neoplasms
Sites in Denver +21 more locations
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT07129252·Phase 1, Phase 2·Recruiting·Listed Aug 2025
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
for Solid Malignancies
Sites in Denver +16 more locations
Sponsor: Immunome, Inc.
Sex: All·Age: 18+
Code: NCT06823167·Phase 1·Recruiting·Listed Feb 2025
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Denver, Aurora +9 more locations
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All·Age: 18+
Code: NCT06384352·Phase 1·Recruiting·Listed Apr 2024
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
for Gastric or Gastroesophageal Junction Adenocarcinoma
Sites in Denver +9 more locations
Sponsor: Phanes Therapeutics
Sex: All·Age: 18+
Code: NCT05482893·Phase 1, Phase 2·Recruiting·Listed Aug 2022
Study of HLD-0915 in Patients With Metastatic Prostate Cancer
for Metastatic Prostate Cancer
Sites in Denver +10 more locations
Sponsor: Halda Therapeutics OpCo, Inc.
Sex: Male·Age: 18+
Code: NCT06800313·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
for Advanced Solid Tumor
Sites in Denver +2 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT04145622·Phase 1, Phase 2·Recruiting·Listed Oct 2019
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for Solid Tumor
Sites in Denver +10 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT06619587·Phase 1·Recruiting·Listed Oct 2024
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Denver +13 more locations
Sponsor: Eikon Therapeutics
Sex: All·Age: 18 - 89
Code: NCT06253130·Phase 1, Phase 2·Recruiting·Listed Feb 2024
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
for Advanced Solid Tumor
Drug: NXP900
Sites in Denver +12 more locations
Sponsor: Nuvectis Pharma, Inc.
Sex: All·Age: 18+
Code: NCT05873686·Phase 1·Recruiting·Listed May 2023
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
for PDAC
Sites in Denver +17 more locations
Sponsor: Tango Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06922591·Phase 1, Phase 2·Recruiting·Listed Apr 2025
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
for Platinum-resistant Ovarian Cancer
Sites in Denver +8 more locations
Sponsor: Context Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT06515613·Phase 1·Recruiting·Listed Jul 2024
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
for Hematologic Malignancies
Drug: Nemtabrutinib
Sites in Denver +6 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT04728893·Phase 2·Recruiting·Listed Jan 2021
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
for Metastatic Uveal Melanoma
Sites in Denver +6 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT03947385·Phase 1, Phase 2·Recruiting·Listed May 2019
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
for Solid Tumors
Drug: INCB161734
Sites in Denver +12 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06179160·Phase 1·Recruiting·Listed Dec 2023
A Study of PYX-201 in Advanced Solid Tumors
for Solid Tumor
Sites in Denver +16 more locations
Sponsor: Pyxis Oncology, Inc
Sex: All·Age: 18+
Code: NCT05720117·Phase 1·Recruiting·Listed Feb 2023
QTX3034 in Patients With KRAS G12D Mutation
for Solid Tumors
Sites in Denver +13 more locations
Sponsor: Quanta Therapeutics
Sex: All·Age: 18+
Code: NCT06227377·Phase 1·Recruiting·Listed Jan 2024
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
for Solid Tumor
Sites in Denver +14 more locations
Sponsor: NiKang Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06586957·Phase 1·Recruiting·Listed Sep 2024
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
for Advanced Cancer
Sites in Denver +14 more locations
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT05557045·Phase 1·Recruiting·Listed Sep 2022
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for Metastatic Solid Tumor
Sites in Denver, Aurora +14 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06561685·Phase 1·Recruiting·Listed Aug 2024
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
for Oncology
Sites in Denver +12 more locations
Sponsor: Nested Therapeutics, Inc
Sex: All·Age: 18+
Code: NCT06326411·Phase 1·Recruiting·Listed Mar 2024
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
for Multiple Myeloma
Drug: Linvoseltamab
Sites in Denver +12 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT05828511·Phase 1, Phase 2·Recruiting·Listed Apr 2023
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
for Ovarian Cancer
Sites in Denver +9 more locations
Sponsor: Nammi Therapeutics Inc
Sex: All·Age: 18+
Code: NCT06582017·Phase 1·Recruiting·Listed Sep 2024
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
for Cancer
Sites in Denver +10 more locations
Sponsor: Conjupro Biotherapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05948865·Phase 1·Recruiting·Listed Jul 2023
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for Solid Tumor Malignancies
Sites in Denver +12 more locations
Sponsor: Tasca Therapeutics
Sex: All·Age: 18+
Code: NCT07030257·Phase 1, Phase 2·Recruiting·Listed Jun 2025
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
for Locally Advanced Solid Tumor
Sites in Denver +16 more locations
Sponsor: Nuvalent Inc.
Sex: All·Age: 18+
Code: NCT06521554·Phase 1·Recruiting·Listed Jul 2024
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for Solid Tumor, Adult
Sites in Denver +8 more locations
Sponsor: Kumquat Biosciences Inc.
Sex: All·Age: 18+
Code: NCT06507306·Phase 1·Recruiting·Listed Jul 2024
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
for Advanced Solid Tumor
Sites in Denver +9 more locations
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06108050·Phase 1·Recruiting·Listed Oct 2023
Conditions in Oncology (Denver, CO)
Solid tumor· 49Breast cancer· 25Non-small cell lung cancer (NSCLC)· 20Cancer (any)· 17Colorectal cancer· 16Multiple myeloma· 15Ovarian cancer· 13Pancreatic cancer· 11Endometrial cancer· 10Acute myeloid leukemia (AML)· 10Non-Hodgkin lymphoma· 10Prostate cancer· 9Gastric cancer· 8Esophageal cancer· 8Hematologic malignancy· 8Melanoma· 7Bladder cancer· 6Leukemia (other)· 6Head and neck cancer· 6Metastatic breast cancer· 5Triple-negative breast cancer· 5Lung cancer· 5Colon cancer· 5Cervical cancer· 5Diffuse large B-cell lymphoma (DLBCL)· 5HER2-negative breast cancer· 4Kidney cancer· 4Myelodysplastic syndromes (MDS)· 4Hodgkin lymphoma· 4Follicular lymphoma· 4Biliary tract cancer· 3Metastatic prostate cancer· 3Chronic lymphocytic leukemia (CLL)· 3Mantle cell lymphoma· 3Marginal zone lymphoma· 3Mesothelioma· 3Neuroendocrine tumors· 3HER2-positive breast cancer· 2Small cell lung cancer· 2Rectal cancer· 2Gastroesophageal junction cancer· 2Glioblastoma· 2Acute lymphoblastic leukemia· 2Myelofibrosis· 2Myeloproliferative neoplasm· 2Small lymphocytic lymphoma· 2Metastatic colorectal cancer· 1Liver cancer· 1Gastrointestinal cancer· 1Fallopian tube cancer· 1Glioma· 1Brain cancer· 1Burkitt lymphoma· 1Thyroid cancer· 1Sarcoma· 1Osteosarcoma· 1Neuroblastoma· 1